COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency
Language English Country Czech Republic Media print-electronic
Document type Journal Article, Review
PubMed
33542545
DOI
10.5507/bp.2021.011
Knihovny.cz E-resources
- Keywords
- SARS-CoV-2, adrenal cortex, adrenal insufficiency, glucocorticoids, severe acute respiratory syndrome,
- MeSH
- Adrenal Insufficiency complications drug therapy metabolism MeSH
- COVID-19 complications therapy MeSH
- Stress, Physiological MeSH
- Glucocorticoids therapeutic use MeSH
- Hormone Replacement Therapy methods MeSH
- Hospitalization MeSH
- Hydrocortisone therapeutic use MeSH
- Humans MeSH
- Disease Management MeSH
- Adrenal Glands metabolism MeSH
- Disease Progression MeSH
- SARS-CoV-2 MeSH
- Inflammation MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Glucocorticoids MeSH
- Hydrocortisone MeSH
The current Coronavirus disease outbreak requires that physicians work in collaboration with other physicians especially in intensive care and emergency units. To fight against this new disease, whose pathogenesis, effects, and results have not been clearly demonstrated, especially in patients with the pre-existing chronic disease, requires special expertise and perspectives. Due to the need for dynamic glucocorticoid treatment at different stages of the disease in patients with adrenal insufficiency, the existence of reports indicating that "coronavirus disease 2019" also affects the adrenal reserve, and the use of glucocorticoids also in advanced stages in patients with Coronavirus disease require this issue to be emphasized with precision. Herein, treatment of the pre-existing adrenal insufficiency in patients with actual Coronavirus disease and the effects of the this critical disease on the adrenal gland have been reviewed.
References provided by Crossref.org
Is there impact of the SARS-CoV-2 pandemic on steroidogenesis and fertility?
